{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:31:25Z","timestamp":1784748685567,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite improvements in diagnosis, intensive-care medicine and surgical technique, the mortality of patients with secondary peritonitis is still high. Early and aggressive empiric antibiotic treatment has strong impact on the outcome. This retrospective study investigates bacterial and fungal pathogens and their antibiotic sensitivity in patients with secondary peritonitis. All patients that underwent emergency laparotomy due to secondary peritonitis at the Department of Surgery, University Medical Center Hamburg-Eppendorf between 2005 and 2015 were reviewed and overall 414 patients were included. We correlated the intra-abdominal localization of the organ perforation with intraoperative microbiological findings and corresponding sensitivities to relevant antibiotics. Overall, the most common findings were <jats:italic>Escherichia coli<\/jats:italic> (39%) and other Enterobacterica (24%). Depending on the location of the perforation, Cefuroxime\/Metronidazole and Cefutaxime\/Metronidazole were effective (based on in vitro susceptibility testing) in only 55\u201373% of the patients, while Meropenem\/Vancomycin was able to control the peritonitis in more than 98% of the patients; independent of the location. Besides early source control, appropriate empiric treatment plays a pivotal role in treatment of secondary peritonitis. We are able to show that the frequently used combinations of second or third generation Cephalosporins with Metronidazole are not always sufficient, which is due to the biological resistance of the bacteria. Further clinical studies are needed to determine whether calculated use of broad-spectrum antibiotics with a sensitivity rate\u2009&gt;\u200999%, such as Carbapenem plus Vancomycin, can improve overall survival rates in critically ill patients with secondary peritonitis.<\/jats:p>","DOI":"10.1038\/s41598-020-73356-x","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T11:02:54Z","timestamp":1603969374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antibiotic sensitivity in correlation to the origin of secondary peritonitis: a single center analysis"],"prefix":"10.1038","volume":"10","author":[{"given":"Rainer","family":"Grotel\u00fcschen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M.","family":"Heidelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9468-7944","authenticated-orcid":false,"given":"Marc","family":"L\u00fctgehetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Melling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Reeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1894-9893","authenticated-orcid":false,"given":"Tarik","family":"Ghadban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dupree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob R.","family":"Izbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai A.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"issue":"Suppl 1","key":"73356_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1179\/joc.2009.21.Supplement-1.3","volume":"21","author":"F Menichetti","year":"2009","unstructured":"Menichetti, F. & Sganga, G. Definition and classification of intra-abdominal infections. J. Chemother. (Florence, Italy) 21(Suppl 1), 3\u20134. https:\/\/doi.org\/10.1179\/joc.2009.21.Supplement-1.3 (2009).","journal-title":"J. Chemother. (Florence, Italy)"},{"key":"73356_CR2","doi-asserted-by":"publisher","first-page":"e769","DOI":"10.1016\/j.ijid.2011.06.008","volume":"15","author":"C Theunissen","year":"2011","unstructured":"Theunissen, C., Cherifi, S. & Karmali, R. Management and outcome of high-risk peritonitis: A retrospective survey 2005\u20132009. Int. J. Infect. Dis. 15, e769-773. https:\/\/doi.org\/10.1016\/j.ijid.2011.06.008 (2011).","journal-title":"Int. J. Infect. Dis."},{"key":"73356_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10096-011-1357-0","volume":"31","author":"O van Ruler","year":"2012","unstructured":"van Ruler, O., Kiewiet, J. J., van Ketel, R. J. & Boermeester, M. A. Initial microbial spectrum in severe secondary peritonitis and relevance for treatment. Eur. J. Clin. Microbiol. Infect. Dis. 31, 671\u2013682. https:\/\/doi.org\/10.1007\/s10096-011-1357-0 (2012).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"73356_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes, A. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 43, 304\u2013377. https:\/\/doi.org\/10.1007\/s00134-017-4683-6 (2017).","journal-title":"Intensive Care Med."},{"key":"73356_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.amjsurg.2011.07.019","volume":"204","author":"D Ruttinger","year":"2012","unstructured":"Ruttinger, D. et al. Acute prognosis of critically ill patients with secondary peritonitis: The impact of the number of surgical revisions, and of the duration of surgical therapy. Am. J. Surg. 204, 28\u201336. https:\/\/doi.org\/10.1016\/j.amjsurg.2011.07.019 (2012).","journal-title":"Am. J. Surg."},{"key":"73356_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/145749690709600302","volume":"96","author":"FM Pieracci","year":"2007","unstructured":"Pieracci, F. M. & Barie, P. S. Management of severe sepsis of abdominal origin. Scand. J. Surg. 96, 184\u2013196 (2007).","journal-title":"Scand. J. Surg."},{"key":"73356_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/sur.2016.261","volume":"18","author":"JE Mazuski","year":"2017","unstructured":"Mazuski, J. E. et al. The Surgical infection society revised guidelines on the management of intra-abdominal infection. Surg. Infect. 18, 1\u201376. https:\/\/doi.org\/10.1089\/sur.2016.261 (2017).","journal-title":"Surg. Infect."},{"key":"73356_CR8","first-page":"179","volume":"19","author":"K Bodmann","year":"2010","unstructured":"Bodmann, K. & Grabein, B. Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen Update 2010. Chemother. J. 19, 179\u2013255 (2010).","journal-title":"Chemother. J."},{"key":"73356_CR9","unstructured":"Baron Barshak, M. Antimicrobial Approach to Intra-abdominal Infections in Adults. https:\/\/www.uptodate.com (2020)."},{"key":"73356_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2146\/ajhp090360","volume":"68","author":"SJ Johnson","year":"2011","unstructured":"Johnson, S. J., Ernst, E. J. & Moores, K. G. Is double coverage of gram-negative organisms necessary?. Am. J. Health Syst. Pharm. 68, 119\u2013124. https:\/\/doi.org\/10.2146\/ajhp090360 (2011).","journal-title":"Am. J. Health Syst. Pharm."},{"key":"73356_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004539.pub2","author":"PF Wong","year":"2005","unstructured":"Wong, P. F. et al. Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD004539.pub2 (2005).","journal-title":"Cochrane Database Syst. Rev."},{"key":"73356_CR12","unstructured":"Gilbert, D., Eliopoulos, G., Chambers, H., Saag, M. & Pavia, A. Antimicrobial Therapy. Vol. 47. The Sanford Guide to Antimicrobial Therapy. https:\/\/store.sanfordguide.com\/antimicrobial-therapy-c2.aspx (2017)."},{"key":"73356_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13017-017-0132-7","volume":"12","author":"M Sartelli","year":"2017","unstructured":"Sartelli, M. et al. Management of intra-abdominal infections: Recommendations by the WSES 2016 consensus conference. World J. Emerg. Surg. 12, 22. https:\/\/doi.org\/10.1186\/s13017-017-0132-7 (2017).","journal-title":"World J. Emerg. Surg."},{"key":"73356_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijsu.2015.12.063","volume":"26","author":"F Coccolini","year":"2016","unstructured":"Coccolini, F. et al. Antibiotic resistance evaluation and clinical analysis of acute appendicitis; report of 1431 consecutive worldwide patients: A cohort study. Int. J. Surg. 26, 6\u201311. https:\/\/doi.org\/10.1016\/j.ijsu.2015.12.063 (2016).","journal-title":"Int. J. Surg."},{"key":"73356_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1345\/aph.1D132","volume":"38","author":"OM Klibanov","year":"2004","unstructured":"Klibanov, O. M., Raasch, R. H. & Rublein, J. C. Single versus combined antibiotic therapy for gram-negative infections. Ann. Pharmacother. 38, 332\u2013337. https:\/\/doi.org\/10.1345\/aph.1D132 (2004).","journal-title":"Ann. Pharmacother."},{"key":"73356_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijsu.2015.07.013","volume":"21","author":"F Coccolini","year":"2015","unstructured":"Coccolini, F. et al. Antibiotic resistance pattern and clinical outcomes in acute cholecystitis: 567 consecutive worldwide patients in a prospective cohort study. Int. J. Surg. 21, 32\u201337. https:\/\/doi.org\/10.1016\/j.ijsu.2015.07.013 (2015).","journal-title":"Int. J. Surg."},{"key":"73356_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.clinthera.2007.05.018","volume":"29","author":"KJ Eagye","year":"2007","unstructured":"Eagye, K. J., Kuti, J. L., Dowzicky, M. & Nicolau, D. P. Empiric therapy for secondary peritonitis: A pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin\/tazobactam, and tigecycline using Monte Carlo simulation. Clin. Ther. 29, 889\u2013899. https:\/\/doi.org\/10.1016\/j.clinthera.2007.05.018 (2007).","journal-title":"Clin. Ther."},{"key":"73356_CR18","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2165\/00003495-200565120-00002","volume":"65","author":"S Blot","year":"2005","unstructured":"Blot, S. & De Waele, J. J. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs 65, 1611\u20131620 (2005).","journal-title":"Drugs"},{"key":"73356_CR19","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1128\/AAC.44.8.2028-2033.2000","volume":"44","author":"H Dupont","year":"2000","unstructured":"Dupont, H., Carbon, C. & Carlet, J. Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: A multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob. Agents Chemother. 44, 2028\u20132033 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"73356_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00000658-199603000-00012","volume":"223","author":"JS Solomkin","year":"1996","unstructured":"Solomkin, J. S. et al. Results of a randomized trial comparing sequential intravenous\/oral treatment with ciprofloxacin plus metronidazole to imipenem\/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group. Ann. Surg. 223, 303\u2013315 (1996).","journal-title":"Ann. Surg."},{"issue":"Suppl 1","key":"73356_CR21","first-page":"34","volume":"30","author":"A Montero","year":"2017","unstructured":"Montero, A., Salgado Aranda, P., Gilsanz, F. & Maseda, E. Antimicrobial management in nosocomial peritonitis: Microbiota, drug and time. Rev. Esp. Quimioter. 30(Suppl 1), 34\u201338 (2017).","journal-title":"Rev. Esp. Quimioter."},{"key":"73356_CR22","first-page":"11","volume":"21","author":"AW Chow","year":"2010","unstructured":"Chow, A. W. et al. Canadian practice guidelines for surgical intra-abdominal infections. Can. J. Infect. Dis. Med. Microbiol. = Journal canadien des maladies infectieuses et de la microbiologie medicale \/ AMMI Canada 21, 11\u201337 (2010).","journal-title":"Can. J. Infect. Dis. Med. Microbiol. = Journal canadien des maladies infectieuses et de la microbiologie medicale \/ AMMI Canada"},{"key":"73356_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s15010-015-0854-y","volume":"44","author":"JP Borde","year":"2016","unstructured":"Borde, J. P. et al. Implementing an intensified antibiotic stewardship programme targeting daptomycin use in orthopaedic surgery: A cost-benefit analysis from the hospital perspective. Infection 44, 301\u2013307. https:\/\/doi.org\/10.1007\/s15010-015-0854-y (2016).","journal-title":"Infection"},{"key":"73356_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1586\/14787210.2015.1040766","volume":"13","author":"SC Reddy","year":"2015","unstructured":"Reddy, S. C., Jacob, J. T., Varkey, J. B. & Gaynes, R. P. Antibiotic use in US hospitals: Quantification, quality measures and stewardship. Expert Rev. Anti-Infect. Ther. 13, 843\u2013854. https:\/\/doi.org\/10.1586\/14787210.2015.1040766 (2015).","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"73356_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2217\/fmb.10.87","volume":"5","author":"J Lumb","year":"2010","unstructured":"Lumb, J. Carbapenems in the treatment of intra-abdominal infection. Report from the 20th European congress of clinical microbiology and infectious diseases. Vienna, Austria, 10\u201313 April 2010. Future Microbiol. 5, 1165\u20131166. https:\/\/doi.org\/10.2217\/fmb.10.87 (2010).","journal-title":"Future Microbiol."},{"key":"73356_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00000658-199607000-00003","volume":"224","author":"DH Wittmann","year":"1996","unstructured":"Wittmann, D. H., Schein, M. & Condon, R. E. Management of secondary peritonitis. Ann. Surg. 224, 10\u201318 (1996).","journal-title":"Ann. Surg."},{"key":"73356_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/IAI.65.1.144-149.1997","volume":"65","author":"P Montravers","year":"1997","unstructured":"Montravers, P., Mohler, J., Saint Julien, L. & Carbon, C. Evidence of the proinflammatory role of Enterococcus faecalis in polymicrobial peritonitis in rats. Infect. Immun. 65, 144\u2013149 (1997).","journal-title":"Infect. Immun."},{"key":"73356_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/jac\/dkf167","volume":"50","author":"A Sotto","year":"2002","unstructured":"Sotto, A. et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J. Antimicrob. Chemother. 50, 569\u2013576 (2002).","journal-title":"J. Antimicrob. Chemother."},{"key":"73356_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12941-015-0110-4","volume":"14","author":"CL Steinbach","year":"2015","unstructured":"Steinbach, C. L., Topper, C., Adam, T. & Kees, M. G. Spectrum adequacy of antibiotic regimens for secondary peritonitis: A retrospective analysis in intermediate and intensive care unit patients. Ann. Clin. Microbiol. Antimicrob. 14, 48. https:\/\/doi.org\/10.1186\/s12941-015-0110-4 (2015).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"73356_CR30","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1089\/sur.2013.240","volume":"15","author":"E Membrilla-Fernandez","year":"2014","unstructured":"Membrilla-Fernandez, E., Sancho-Insenser, J. J., Girvent-Montllor, M., Alvarez-Lerma, F. & Sitges-Serra, A. Effect of initial empiric antibiotic therapy combined with control of the infection focus on the prognosis of patients with secondary peritonitis. Surg. Infect. 15, 806\u2013814. https:\/\/doi.org\/10.1089\/sur.2013.240 (2014).","journal-title":"Surg. Infect."},{"key":"73356_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s00134-006-0517-7","volume":"33","author":"C Engel","year":"2007","unstructured":"Engel, C. et al. Epidemiology of sepsis in Germany: Results from a national prospective multicenter study. Intensive Care Med. 33, 606\u2013618. https:\/\/doi.org\/10.1007\/s00134-006-0517-7 (2007).","journal-title":"Intensive Care Med."},{"key":"73356_CR32","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/cid\/civ097","volume":"60","author":"J Solomkin","year":"2015","unstructured":"Solomkin, J. et al. Ceftolozane\/Tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: Results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI). Clin. Infect. Dis. 60, 1462\u20131471. https:\/\/doi.org\/10.1093\/cid\/civ097 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"73356_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5603\/ait.2014.0043","volume":"46","author":"G Pupelis","year":"2014","unstructured":"Pupelis, G., Drozdova, N., Mukans, M. & Malbrain, M. L. Serum procalcitonin is a sensitive marker for septic shock and mortality in secondary peritonitis. Anaesthesiol. Intensive Ther. 46, 262\u2013273. https:\/\/doi.org\/10.5603\/ait.2014.0043 (2014).","journal-title":"Anaesthesiol. Intensive Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73356-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73356-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73356-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:22:57Z","timestamp":1670365377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73356-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73356"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73356-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,29]]},"assertion":[{"value":"8 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18588"}}